EcoDrugPlus


Synonyms	Patiromer calcium Patiromer glucitol calcium Patiromer sorbitex calcium RLY-5016 RLY-5016S RLY5016 RLY5016S Veltassa
Status
Molecule Category	UNKNOWN
ATC	V03AE09
UNII	7T97I3787N

Synonyms

Patiromer calcium

Patiromer glucitol calcium

Patiromer sorbitex calcium

RLY-5016

RLY-5016S

RLY5016

RLY5016S

Veltassa

Status

Molecule Category

UNKNOWN

ATC

V03AE09

UNII

7T97I3787N


Active Pharmaceutical Ingredients Bioactive chemicals	Exact Similarity SubStructure	Threshold (%) >= 70

Mechanism of Action	Action	Reference
Potassium chelating agent	CHELATING AGENT	FDA

Mechanism of Action

Action

Reference

Potassium chelating agent

CHELATING AGENT

FDA

Resources	Reference
ChEMBL	CHEMBL2107840
FDA SRS	7T97I3787N

Resources

Reference

ChEMBL

CHEMBL2107840

FDA SRS

7T97I3787N


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PATIROMER CALCIUM

Bioactivity

Cross References